Paola Malerba

发表

Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer

Andrew J. Wilson, M. J. Uddin, L. Marnett, 2019, ACS omega.

Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.

A. Lavecchia, E. Marcantoni, M. Perrone, 2013, Journal of medicinal chemistry.

Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles.

A. Lavecchia, M. Perrone, A. Scilimati, 2014, European journal of medicinal chemistry.

Diarylheterocycle Core Ring Features Effect in Selective COX‐1 Inhibition

E. Novellino, A. Lavecchia, A. Altomare, 2012, ChemMedChem.

Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells.

A. Cianciulli, R. Calvello, M. Panaro, 2012, Pharmacological research.

Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer.

M. J. Uddin, L. Marnett, K. Ghebreselasie, 2019, ACS medicinal chemistry letters.

PET radiotracer [¹⁸F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: preliminary investigation.

L. Marnett, M. Perrone, H. Manning, 2014, European journal of medicinal chemistry.

Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.

A. Lavecchia, M. Perrone, S. Tacconelli, 2013, Journal of medicinal chemistry.

Diarylheterocycle Core Ring Features Effect in Selective COX‐1 Inhibition

E. Novellino, A. Lavecchia, A. Altomare, 2012, ChemMedChem.